KDR and cancer: VEGF signaling through its cognate receptor VEGFR2 dismantles endothelial cell junctions and promotes the degradation of the vascular basement membrane through secretion of matrix metalloproteases (MMPs), thereby facilitating cancer cell intravasation and metastasis (4–6).